David Einhorn Boosts Acadia Healthcare Stock with Big Buy Reveal
Hedge fund legend David Einhorn revealed on CNBC that he's buying shares of Acadia Healthcare, sending the stock up 12% in a day.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Hedge fund legend David Einhorn revealed on CNBC that he's buying shares of Acadia Healthcare, sending the stock up 12% in a day.
Baker Hughes is exploring a potential sale of its Waygate Technologies business, which makes industrial inspection tools, amid efforts to focus on core operations after big acquisitions.
Software stocks are falling sharply after disappointing earnings and guidance from companies like Dassault Systèmes and Unity Software, raising worries about AI disrupting traditional business models.
Micron shares jump over 6% as CFO announces ahead-of-schedule HBM4 production and shipments, easing competition worries amid booming AI memory demand. Analysts boost targets on tight supply outlook.
Vinay Prasad, FDA's biologics director, overruled staff to refuse reviewing Moderna's new mRNA flu vaccine, citing trial design issues. HHS denies overruling occurred amid ongoing debate on vaccine scrutiny.
Goldman Sachs starts coverage on Energy Fuels with a Buy rating and $30 price target, highlighting its top uranium assets, unique US mill, and future growth in heavy mineral sands.